Table 3.
Gene | Exon/intron | Nucleotide change | Amino acid change | Variant type | dbSNP rs | Clinical significance | Database report | Frequency (n) |
---|---|---|---|---|---|---|---|---|
BRCA1 | Exon 2 | c.66dup | p.Glu23Arg | Duplication/fs | rs80357783 | Pathogenic | Yes | 5 |
BRCA1 | Exon 12 | c.4117G > T | p.Glu1373Ter | Nonsense | rs80357259 | Pathogenic | Yes | 3 |
BRCA1 | Intron 17 | c.5074 + 3A > G | Splice acceptor | Intervening sequence | rs80358181 | Likely pathogenic | Yes | 3 |
BRCA1 | Exon 11 | c.4065_4068del | p.Asn1355Lys | Deletion/fs | rs80357508 | Pathogenic | Yes | 2 |
BRCA1 | Exon 18 | c.5123C > A | p.Ala1708Glu | Missense | rs28897696 | Pathogenic | Yes | 2 |
BRCA1 | Exon 3 | c.121C > T | p.His41Tyr | Missense | rs1060502353 | Likely pathogenic | Yes | 2 |
BRCA2 | Exon 11 | c.2254_2257 del | p.Asp752Phefs | Deletion/fs | rs80359326 | Pathogenic | Yes | 8 |
BRCA2 | Exon 11/Exon 11 | c.2254_2257 del & c.5351 dup | p.Asp752Phefs and p.Asn1784Lysfs | Deletion/fs-Duplication/fs | rs80359326 & rs80359508 | Pathogenic | Yes | 6 |
BRCA2 | Exons 5-11 | Partial duplication (exons 5-11) | Absent or disrupted protein product | Large duplication | — | Pathogenic | Yes | 5 |
BRCA2 | Exon 10 | c.1233dup | p.Pro412Thr | Duplication/fs | rs80359270 | Pathogenic | Yes | 3 |
BRCA2 | Exon 11 | c.6685G > T | p.Glu2229Ter | Nonsense | rs730881548 | Pathogenic | Yes | 3 |
BRCA2 | Exon 11 | c.6486_6489del | p.Lys2162Asn | Deletion/fs | rs80359598 | Pathogenic | Yes | 2 |
BRCA2 | Intron 24 | c.9257-1G > A | Splice acceptor | Intervening sequence | rs81002889 | Likely pathogenic | Yes | 2 |